Cite

HARVARD Citation

    Wistuba-Hamprecht, K. et al. (2017). Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients. European journal of cancer. pp. 61-70. [Online]. 
  
Back to record